Our multidisciplinary team aims to provide care and support for patients and their families. Patients are routinely (every three months) seen by specialists in our team. Together with the NeuroCenter Network we coordinate medical, paramedical and social support at home for patients. We also take part in various research activities. These are directed to identify ALS risk genes, new biomarkers for diagnosis and prognosis, and clinical studies to develop suitable treatments. Finally, we are setting up an ALS Registry in the Center Val de Loire.
Contact
LocationCHU Bretonneau 2 Boulevard Tonnellé, 37044 Tours
Specialists
Current trials
In preparation
Phase iii
The Lighthouse 2 trial
Investigator initiated trial
The Lighthouse 2 study is a phase 3 clinical trial in which we will investigate the efficacy of the drug Triumeq.
In preparation
Phase iii
MAGNET
Platform trial
MAGNET is an innovative clinical platform trial in which multiple treatments for ALS are investigated simultaneously.
Recruiting
Phase iii
TUDCA-ALS (TUDCA)
Investigator initiated trial
This trial will evaluate the efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment for people with ALS.